Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × efgartigimod alfa × Clear all

Phase

Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Propofol 8 Sevoflurane 6 Dexamethasone 6 Rituximab 5 Magnetic Resonance Spectroscopy 5 Nivolumab 4 Indocyanine Green 4 Capecitabine 4 Bupivacaine 4 Bevacizumab 4 Trastuzumab 3 Surgical Procedures, Operative 3 Standard of Care 3 Specimen Handling 3 Saline Solution 3 Metformin 3 Lenalidomide 3 Gemcitabine 3 Fluorouracil 3 Enoxaparin 3 Carboplatin 3 Acetaminophen 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 trametinib 2 tislelizumab 2 semaglutide 2 ribociclib 2 polyethylene glycol 3350 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07072988 2025-09-24

OPTIMAGE

Centre Hospitalier Universitaire de Nice

Phase 4 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡